Biotech company on the hunt for a partner at the year's most important conference

Scandion Oncology will meet with several representatives from large and medium-sized businesses at this year's JP Morgan conference. The hope is that the business will meet a future partner.

Nils Brünner, CEO and co-founder of Scandion Oncology is participating in the JP Morgan conference in San Francisco, which is the year's most important conference for the life science industry, for the first time. Photo: Scandion Oncology

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles